Muyang Cao
Papers
1
Total Citations
12
H-Index
1
About
Dr. Muyang Cao is a pioneering urologic surgeon and researcher advancing the frontiers of robotic-assisted surgery, with a primary focus on kidney and prostate cancer interventions. His most impactful work lies in the comparative evaluation of emerging Chinese robotic surgical systems—the KangDuo-SR-2000 and EDGE MP1000—against the established Da Vinci Xi platform. In a landmark prospective, single-center, non-randomized clinical trial (2025), Dr. Cao demonstrated that these domestic systems achieve comparable perioperative outcomes for partial nephrectomy and radical prostatectomy, offering a cost-effective alternative that could democratize access to minimally invasive surgery. This study, already garnering 12 citations, positions him at the vanguard of surgical technology validation. Beyond this, his research portfolio encompasses optimizing robotic techniques to reduce operative times and improve oncologic control. Dr. Cao’s contributions are not merely technical; they carry profound implications for global health equity, as his work directly supports the localization of advanced surgical platforms. For students and researchers, his career exemplifies how rigorous clinical trials can bridge innovation and practice, reshaping the landscape of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1